Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F7 | P08709 | 3/20 | 1.00 |
| ▸ | F3 | P13726 | 3/20 | 1.00 |
| ▸ | MMP2 | P08253 | 2/20 | 1.00 |
| ▸ | SAE1 | Q9UBE0 | 2/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 1.00 |
| ▸ | MAPT | P10636 | 1/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 1/20 | 1.00 |
| ▸ | ECE1 | P42892 | 1/20 | 1.00 |
| ▸ | SGMS1 | Q86VZ5 | 1/20 | 1.00 |
| ▸ | SGMS2 | Q8NHU3 | 1/20 | 1.00 |
| ▸ | MUS81 | Q96NY9 | 1/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 1.00 |
| ▸ | BID | P55957 | 7/20 | 0.95 |
| ▸ | MCL1 | Q07820 | 7/20 | 0.95 |
| ▸ | BCL2L1 | Q07817 | 6/20 | 0.95 |
| ▸ | BAK1 | Q16611 | 6/20 | 0.95 |
| ▸ | KAT8 | Q9H7Z6 | 4/20 | 0.84 |
| ▸ | EP300 | Q09472 | 3/20 | 0.84 |
| ▸ | KAT5 | Q92993 | 3/20 | 0.84 |
| ▸ | KAT2B | Q92831 | 2/20 | 0.84 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5370295 | 1.00 | F7 (1.00) | F7F3MMP2SAE1KDM4E | |
| SCHEMBL5394786 | 1.00 | F7 (1.00) | F7F3MMP2SAE1KDM4E | |
| SCHEMBL5370300 | 1.00 | F7 (1.00) | F7F3MMP2SAE1KDM4E | |
| Ginkgolic Acid 17:1 SCHEMBL5380765 | 1.00 | F7 (1.00) | F7F3MMP2SAE1KDM4E | |
| SCHEMBL13311658 | 1.00 | F7 (1.00) | F7F3MMP2SAE1KDM4E | |
| Ginkgolic Acid 17:1 SCHEMBL5380767 | 1.00 | F7 (1.00) | F7F3MMP2SAE1KDM4E | |
| Ginkgolic Acid 17:1 SCHEMBL5380775 | 1.00 | F7 (1.00) | F7F3MMP2SAE1KDM4E | |
| Gingkolic Acid SCHEMBL8040660 | 1.00 | F7 (1.00) | F7F3MMP2SAE1KDM4E | |
| SCHEMBL5370293 | 1.00 | F7 (1.00) | F7F3MMP2SAE1KDM4E | |
| Gingkolic Acid SCHEMBL8042802 | 1.00 | F7 (1.00) | F7F3MMP2SAE1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2777 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4674894-A2 | COPOLYMERS OF N-VINYLPYRROLIDONE WITH FUNCTIONALIZED MALEIC ACID MOIETIES | Hemoteq AG (DE) | 2026-01-07 | — | — | EP | claimed |
| EP-4663688-A2 | CROSSLINKERS | Hemoteq AG (DE) | 2025-12-17 | — | — | EP | claimed |
| US-20250326910-A1 | METHOD FOR PRODUCING SURFACE-MODIFIED MICRO-FIBRILLATED CELLULOSE | DÄTWYLER SCHWEIZ AG (CH) | 2025-10-23 | — | — | US | claimed |
| EP-3807287-B1 | METAL COMPLEXES OF BETA-DIKETONES AND/OR POLYPHENOLS BY GREEN CHEMISTRY, PREPARATION METHOD THEREOF, SUNSCREEN THEREOF, SKIN OR HAIR TONE CONCEALER THEREOF, HAIR DYEING THEREOF AND OTHER USES THEREOF | RAMIREZ RIOS LILIANA PATRICIA (NL) | 2025-07-30 | — | — | EP | claimed |
| CN-120158038-A | Flame-retardant phenolic resin molding material and preparation method thereof | 海口市福瑞能科技有限公司 | 2025-06-17 | — | — | CN | claimed |
| EP-4532567-A1 | METHOD FOR PRODUCING SURFACE-MODIFIED MICRO-FIBRILLATED CELLULOSE | Dätwyler Schweiz AG (CH) | 2025-04-09 | — | — | EP | claimed |
| CN-119752736-A | Lactobacillus plantarum NCU0011190 with thrombus prevention effect and application thereof | 南昌大学 | 2025-04-04 | — | — | CN | claimed |
| WO-2025063844-A1 | ENHANCEMENT OF T CELL MEDIATED THERAPIES WITH A DNA HYPOMETHYLATING AGENT AND A SUMOYLATION INHIBITOR | ACADEMISCH ZIEKENHUIS LEIDEN (h.o.d.n. LUMC) (NL) | 2025-03-27 | — | — | WO | claimed |
| US-20250082703-A1 | GINKGO BILOBA KETONE ESTER CAPSULE AND PREPARATION METHOD THEREOF | SPH XING LING SCI. & TECH. PHARMACEUTICAL CO., LTD. (CN) | 2025-03-13 | — | — | US | claimed |
| CN-119424461-A | Application of effective ingredient formula of known cellulitis in treating cardiovascular and cerebrovascular diseases caused by diabetes | 唐宁医药科技(济南)有限公司 | 2025-02-14 | — | — | CN | claimed |
| US-20010055629-A1 | Ginkgo biloba composition, method to prepare the same and uses thereof | SPH XING LING SCI. & TECH. PHARMACEUTICAL CO., LTD. (CN) | 2001-12-27 | — | — | US | claimed |
| EP-0731708-B1 | EXTRACT FROM THE LEAVES OF GINKGO BILOBA | MONTANA LTD (IE) | 2001-09-05 | — | — | EP | claimed |
| US-6174531-B1 | Methods of preparation of bioginkgo | PHARMANEX INC. | 2001-01-16 | — | — | US | claimed |
| EP-1033994-A1 | METHODS OF PREPARATION OF BIOGINKGO | Pharmanex, Inc. (US) | 2000-09-13 | — | — | EP | claimed |
| US-6117431-A | Method for obtaining an extract from ginkgo biloba leaves | PHARMLINE INC. (US) | 2000-09-12 | — | — | US | claimed |
| US-6086883-A | GLYCOLIPIDS AND GINKGOLIC ACIDS | MONTANA LIMITED (IE) | 2000-07-11 | — | — | US | claimed |
| US-6030621-A | Ginkgo biloba composition, method to prepare the same and uses thereof | SPH XINGLING SCI. & TECH. PHARMACEUTICAL CO., LTD (CN) | 2000-02-29 | — | — | US | claimed |
| WO-1999026643-A1 | METHODS OF PREPARATION OF BIOGINKGO | PHARMANEX, INC. (US) | 1999-06-03 | — | — | WO | claimed |
| EP-0731708-A1 | EXTRACT FROM THE LEAVES OF GINKGO BILOBA | MONTANA LIMITED (IE) | 1996-09-18 | — | — | EP | claimed |
| WO-1995015172-A1 | EXTRACT FROM THE LEAVES OF GINGKO BILOBA | MONTANA LIMITED (IE) | 1995-06-08 | — | — | WO | claimed |